Guidance Recipients
Match would-be startups with local industry, academia, and related institutionsHIGH PRECISION BLOOD TEST FOR DETECTION OF BREAST CANCER
Lin Ruo-kai, Taipei Medical University
Year 2021Year
Period:2021-11-01 to
Overview
- Breast cancer tops the global incidence chart for female cancers. While mammography is the most common screening test for breast cancer, some 71% of its results are false positives. What this entails is undeniably a waste of medical resources.
- The team has thus developed a blood test kit to screen for breast cancer. Qualitative testing is done on cell-free DNA with a view to identifying DNA methylation that is specific to breast cancer. In addition to accuracy of up to 90%, this approach has the capacity for detecting breast cancer early on (stage 0, I, and II). Physicians can thus better help women of 20-80 determine if they have breast cancer.
- Complement mammography to enhance accuracy so that patients can secure precise diagnosis and proper treatment early on.
Development Process
Over the course of this project under the Applied Research Incubation Program, the team is set to complete preclinical trials, academic clinical trials, trial production, and LDTS validation.
Milestones
Project Leader
Project ManagerEva Chen SpecializationMolecular biology, oral immunology, murine model building, gene cloning.
More Professional Partners
sabrinawang@biip-mdcc.org
+886-3-658-8760#2031
Project Manager
Eva Chen
Specialization
Molecular biology, oral immunology, murine model building, gene cloning.
Duty
Guidance for teams focusing on IVD kits; drawing on her academic and professional expertise and understanding of applicable regulations to help academic or research teams commercialize their technologies and bring their products to market.
Responsible Team
HIGH PRECISION BLOOD TEST FOR DETECTION OF BREAST CANCER
